Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Hand-and-arm intensive therapy with lower-limb training for children with spastic diplegic cerebral palsy

Official title: Effects of Hand and Arm Bimanual Intensive Therapy Including Lower Extremity on Motor Function and Cognition in Children With Spastic Cerebral Palsy

Run by Lahore University of Biological and Applied Sciences · NCT07253857 · Data updated 2026-11-12

This trial tests whether an intensive bimanual hand-and-arm therapy that also includes lower-limb training (HABIT-ILE) helps children with spastic diplegic cerebral palsy improve motor and thinking skills.

More Cerebral Palsy trials

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment42 (estimated)
SponsorLahore University of Biological and Applied Sciences
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedDecember 20, 2025
Main results expectedJune 2026
Study endsJune 2026
Registry record updatedJune 18, 2026
Trial IDNCT07253857 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children with spastic diplegic cerebral palsy who have MACS and GMFCS levels 1–3, can grasp light objects and lift the more affected arm 15 cm, and score at least 20 on the MMC are the ideal candidates.

Probably not a fit

Children with uncontrolled seizures, recent or planned botulinum toxin within 6 months, recent orthopedic interventions affecting motor function, or visual impairments that prevent participation are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares HABIT-ILE, an intensive bimanual upper-limb program that also targets the lower extremities, with conventional physical therapy in children with spastic diplegic cerebral palsy. Eligible participants have MACS and GMFCS levels 1–3, can grasp light objects and lift the affected arm 15 cm, and have a baseline MMC score of 20 or higher. Outcomes include measures of gross motor function and cognitive/executive performance to determine whether adding lower-limb training produces broader functional gains. The intervention is delivered at a single site in Lahore and participants are randomized to receive either HABIT-ILE or usual therapy.

Why it matters

Potential benefit: If successful, HABIT-ILE could improve both motor abilities and executive cognitive skills, leading to greater independence and quality of life for children with spastic diplegic CP.

How similar studies have gone: Previous HABIT-ILE studies have shown improvements in gross motor function, but evidence for cognitive benefits remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with diplegic cerebral palsy
* CP children with manual ability level 1-3 on manual ability classification system
* Participants with gross motor function classification system level ranging from 1-3 will be included in the study.
* With an ability to grasp light objects and lift the more affected arm 15 cm above a table surface.
* Base line cognition level should be 20 or above assessed through mini mental state exam for children (MMC).

Exclusion Criteria:

* Uncontrolled seizures
* Recent or planned botulinum toxin injections within 6 months
* Any recent orthopedic interventions that may affect motor function
* Visual impairments impeding with treatment protocol

Where it's running

  • Pakistan Society for Rehabilitation of Differently Abled (PSRD)
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.